229 related articles for article (PubMed ID: 27870168)
21. Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12.
Jain R; Kulkarni P; Dhali S; Rapole S; Srivastava S
J Proteomics; 2015 Jan; 113():127-42. PubMed ID: 25286751
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.
Tarassishin L; Lim J; Weatherly DB; Angeletti RH; Lee SC
J Proteomics; 2014 Mar; 99():152-168. PubMed ID: 24503185
[TBL] [Abstract][Full Text] [Related]
23. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
24. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
[TBL] [Abstract][Full Text] [Related]
25. GBM secretome induces transient transformation of human neural precursor cells.
Venugopal C; Wang XS; Manoranjan B; McFarlane N; Nolte S; Li M; Murty N; Siu KW; Singh SK
J Neurooncol; 2012 Sep; 109(3):457-66. PubMed ID: 22752853
[TBL] [Abstract][Full Text] [Related]
26. Proteomic level changes associated with S3I201 treated U87 glioma cells.
Jain R; Atak A; Yeola A; Srivastava S
J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
[TBL] [Abstract][Full Text] [Related]
27. To the novel paradigm of proteome-based cell therapy of tumors: through comparative proteome mapping of tumor stem cells and tissue-specific stem cells of humans.
Bryukhovetskiy A; Shevchenko V; Kovalev S; Chekhonin V; Baklaushev V; Bryukhovetskiy I; Zhukova M
Cell Transplant; 2014; 23 Suppl 1():S151-70. PubMed ID: 25303679
[TBL] [Abstract][Full Text] [Related]
28. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
29. Neural stem cells and glioblastoma.
Rispoli R; Conti C; Celli P; Caroli E; Carletti S
Neuroradiol J; 2014 Apr; 27(2):169-74. PubMed ID: 24750704
[TBL] [Abstract][Full Text] [Related]
30. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
[TBL] [Abstract][Full Text] [Related]
31. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
32. LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.
Polisetty RV; Gautam P; Sharma R; Harsha HC; Nair SC; Gupta MK; Uppin MS; Challa S; Puligopu AK; Ankathi P; Purohit AK; Chandak GR; Pandey A; Sirdeshmukh R
Mol Cell Proteomics; 2012 Jun; 11(6):M111.013565. PubMed ID: 22219345
[TBL] [Abstract][Full Text] [Related]
33. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
34. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
35. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.
Oliveira AI; Anjo SI; Vieira de Castro J; Serra SC; Salgado AJ; Manadas B; Costa BM
Cell Commun Signal; 2017 Oct; 15(1):37. PubMed ID: 28969644
[TBL] [Abstract][Full Text] [Related]
37. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomics.
Autelitano F; Loyaux D; Roudières S; Déon C; Guette F; Fabre P; Ping Q; Wang S; Auvergne R; Badarinarayana V; Smith M; Guillemot JC; Goldman SA; Natesan S; Ferrara P; August P
PLoS One; 2014; 9(10):e110316. PubMed ID: 25360666
[TBL] [Abstract][Full Text] [Related]
39. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
[TBL] [Abstract][Full Text] [Related]
40. Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.
Kaur H; Phillips-Mason PJ; Burden-Gulley SM; Kerstetter-Fogle AE; Basilion JP; Sloan AE; Brady-Kalnay SM
Mol Cancer Res; 2012 Mar; 10(3):293-304. PubMed ID: 22267545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
